Patents by Inventor Anders Alderborn

Anders Alderborn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11975105
    Abstract: The present invention relates to a modified-release composition comprising orlistat and acarbose, comprising individually distinct parts with different release patterns: a) a first part, G1, comprising from about 5 to about 70% w/w of the total dose of acarbose, b) a second part, G2A, comprising from about 30 to about 95% w/w of the total dose of acarbose, c) a third part, G2B, comprising from about 10 to about 90% w/w of the total dose of orlistat, and d) a fourth part, G3, comprising from about 10 to about 80% w/w of the total dose of orlistat, and the total concentration of acarbose and orlistat, respectively, in the composition is 100% w/w.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: May 7, 2024
    Assignee: EMPROS PHARMA AB
    Inventors: Göran Alderborn, Anders Forslund, Ulf Holmbäck, Hans Lennernäs, Jan Stefan Persson Grudén
  • Patent number: 8129174
    Abstract: A method for separating carriers from a solution, the carriers being adapted to have biomolecules, such as DNA, RNA, proteins, polypeptides or carbohydrates attached thereto. The method includes the steps of introducing a tubular member (13) into a receptacle which holds a solution containing the carriers immersing an end portion of the tubular member in the solution attracting and holding the carriers to the end portion and removing the tubular member together with the held carriers from the solution. The attracting and holding step includes the step of providing an under-pressure within the tubular member so as to attract and hold the carriers to a filter (25) being disposed in the end portion of the tubular member. The invention also relates to an apparatus (10) performing such a method.
    Type: Grant
    Filed: February 12, 2003
    Date of Patent: March 6, 2012
    Assignee: Qiagen Instruments AG
    Inventors: Anders Alderborn, David Peterson, Bjorn Ingemarsson, Anna-Lotta Schiller
  • Publication number: 20050019775
    Abstract: The present invention relates to a method for separating carriers from a solution, said carriers being adapted to have biomolecules, such as DNA, RNA, proteins, polypeptides or carbohydrates attached thereto. The method comprises the steps of introducing a tubular member (13) into a receptacle which holds a solution containing said carriers immersing an end portion of the tubular member in the solution attracting and holding said carriers to said end portion and removing said tubular member together with the held carriers from the solution. The method is characterised in that said attracting and holding step comprises the step of providing an under-pressure within the tubular member so as to attract and hold the carriers to a filter (25) being disposed in the end portion of the tubular member. The invention also relates to an apparatus (10) performing such a method.
    Type: Application
    Filed: February 12, 2003
    Publication date: January 27, 2005
    Inventors: Anders Alderborn, David Peterson, Bjorn Ingemarsson, Anna-Lotta Schiller
  • Publication number: 20030138813
    Abstract: This invention relates to a method of determining information about the likely clinical outcome of a microbiological infection in a patient, and also to a method of selecting a suitable therapeutic regimen for a patient with a microbiological infection.
    Type: Application
    Filed: September 24, 2002
    Publication date: July 24, 2003
    Inventors: Lars Engstrand, Anders Alderborn